(Stroke. 1995;26:2154-2159.)
© 1995 American Heart Association, Inc.
Articles |
Basic Fibroblast Growth Factor Increases Regional Cerebral Blood Flow and Reduces Infarct Size After Experimental Ischemia in a Rat Model
From the Departments of Neurosurgery (R.T., Y.M., K.Y.), Critical Care Medicine (T.O.), and Pathology (T.K.), Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.
Correspondence to Ryusui Tanaka, MD, Department of Neurosurgery, Kitasato University School of Medicine, 1-15-1 Kitasato, Sagamihara, Kanagawa, Japan.
Background and Purpose The aim of this study was to ascertain whether basic fibroblast growth factors (bFGF) caused reduction in size of cerebral infarcts in Sprague-Dawley rats with experimental ischemia.
Methods In the first experiment we induced permanent occlusion of the left middle cerebral artery (MCA). Within 5 minutes after MCA occlusion, we infused bFGF (100 ng in 0.1 mL of saline) in the bFGF-treated group (n=14) and 0.1 mL of saline alone in the control group (n=7) into the common carotid artery ipsilateral to MCA occlusion. We harvested the brains 24 hours after MCA occlusion and determined infarct size planimetrically as a percentage of hemisphere size. In the second experiment cerebral blood flow (CBF) was continuously measured for 120 minutes after MCA occlusion in the bFGF-treated group (n=9) and in the control group (n=8) with the use of laser-Doppler flowmetry.
Results Infarct size in the bFGF-treated group decreased significantly in comparison with that in the control group (repeated-measures ANOVA, P<.0001). CBF in the transitional areas between the MCA and the anterior cerebral artery significantly increased in the bFGF-treated group in comparison with that in the control group (repeated-measures ANOVA, P<.005). An approximate 58% decrease in infarct size and a 40% increase in regional CBF were seen on bFGF treatment.
Conclusions The present study suggested that intracarotid administration of bFGF (100 ng) can reduce infarct size after MCA occlusion. It was speculated that the increased CBF in the penumbral areas of MCA may contribute to contraction of infarct size.
Key Words: cerebral infarction • growth factors • laser-Doppler flowmetry • rats
This article has been cited by other articles:
 |
|
 |
|
  W.-R. Schabitz, R. Kollmar, M. Schwaninger, E. Juettler, J. Bardutzky, M.N. Scholzke, C. Sommer, and S. Schwab Neuroprotective Effect of Granulocyte Colony-Stimulating Factor After Focal Cerebral Ischemia Stroke, March 1, 2003; 34(3): 745 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sakurai, T. Nagata, K. Abe, T. Horinouchi, Y. Itoyama, and K. Tabayashi Survival and death-promoting events after transient spinal cord ischemia in rabbits: Induction of Akt and caspase3 in motor neurons J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 370 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-R. Schabitz, T. T. Hoffmann, S. Heiland, R. Kollmar, J. Bardutzky, C. Sommer, and S. Schwab Delayed Neuroprotective Effect of Insulin-Like Growth Factor-I After Experimental Transient Focal Cerebral Ischemia Monitored With MRI Stroke, May 1, 2001; 32(5): 1226 - 1233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Wagle and J. P. Singh Fibroblast Growth Factor Protects Nitric Oxide-Induced Apoptosis in Neuronal SHSY-5Y Cells J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 889 - 895. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Fisher and W. Schaebitz An Overview of Acute Stroke Therapy: Past, Present, and Future Arch Intern Med, November 27, 2000; 160(21): 3196 - 3206. [Full Text] [PDF]
|
|
|
|
|
|
W. R. Schabitz, F. Li, K. Irie, B. W. Sandage Jr, K. W. Locke, M. Fisher, and P. D. Hurn Synergistic Effects of a Combination of Low-Dose Basic Fibroblast Growth Factor and Citicoline After Temporary Experimental Focal Ischemia • Editorial Comment Stroke, February 1, 1999; 30(2): 427 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kitagawa, T. Hayashi, Y. Mitsumoto, N. Koga, Y. Itoyama, K. Abe, and H. A. Kontos Reduction of Ischemic Brain Injury by Topical Application of Glial Cell Line–Derived Neurotrophic Factor After Permanent Middle Cerebral Artery Occlusion in Rats • Editorial Comment Stroke, July 1, 1998; 29(7): 1417 - 1422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tatlisumak, R. A. D. Carano, K. Takano, T. J. Opgenorth, C. H. Sotak, M. Fisher, C. Y. Hsu, and W. Lin A Novel Endothelin Antagonist, A-127722, Attenuates Ischemic Lesion Size in Rats With Temporary Middle Cerebral Artery Occlusion : A Diffusion and Perfusion MRI Study • Editorial Comment: A Diffusion and Perfusion MRI Study Stroke, April 1, 1998; 29(4): 850 - 858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Lin and S. P. Finklestein {blacksquare} REVIEW : Basic Fibroblast Growth Factor: A Treatment for stroke? Neuroscientist, July 1, 1997; 3(4): 247 - 250. [Abstract] [PDF]
|
|
|
|
|
|
A. Bethel, J. R. Kirsch, R. C. Koehler, S. P. Finklestein, and R. J. Traystman Intravenous Basic Fibroblast Growth Factor Decreases Brain Injury Resulting From Focal Ischemia in Cats Stroke, March 1, 1997; 28(3): 609 - 616. [Abstract] [Full Text]
|
|
|
|
|
|
T. Tatlisumak, K. Takano, R. A.D. Carano, M. Fisher, and C. Y. Hsu Effect of Basic Fibroblast Growth Factor on Experimental Focal Ischemia Studied by Diffusion-Weighted and Perfusion Imaging Stroke, December 1, 1996; 27(12): 2292 - 2298. [Abstract] [Full Text]
|
|